Cholera
Cholera, severe infectious disease endemic in India and some other tropical countries and occasionally spreading to temperate climates. The symptoms of cholera are diarrhea and the loss of water and salts in the stool. In severe cholera, the patient develops violent diarrhea with characteristic “rice-water stools,” vomiting, thirst, muscle cramps, and sometimes circulatory collapse. Death can occur as quickly as a few hours after the onset of symptoms. The mortality rate is more than 50 percent in untreated cases, but falls to less than 1 percent with proper treatment.
Treatment consists mainly of intravenous or oral replacement of fluids and salts. Packets for dilution containing the correct mixture of sodium, potassium, chloride, bicarbonate, and glucose have been made widely available by the WHO. Most patients recover in three to six days. Antibiotics such as tetracyclines, ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole can shorten the duration of the disease.
A vaccine made from killed bacteria is commercially available and offers partial protection for a period of three to six months after immunization. Experimental studies have shown that the cholera bacterium produces a toxin that causes the small intestine to secrete large amounts of fluid, which leads to the fluid loss characteristic of the disease. This has led to work on a vaccine containing inactivated toxin. Attempts are also being made to develop a vaccine containing live bacteria that have been altered so that they do not produce the toxin.
Treatment consists mainly of intravenous or oral replacement of fluids and salts. Packets for dilution containing the correct mixture of sodium, potassium, chloride, bicarbonate, and glucose have been made widely available by the WHO. Most patients recover in three to six days. Antibiotics such as tetracyclines, ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole can shorten the duration of the disease.
A vaccine made from killed bacteria is commercially available and offers partial protection for a period of three to six months after immunization. Experimental studies have shown that the cholera bacterium produces a toxin that causes the small intestine to secrete large amounts of fluid, which leads to the fluid loss characteristic of the disease. This has led to work on a vaccine containing inactivated toxin. Attempts are also being made to develop a vaccine containing live bacteria that have been altered so that they do not produce the toxin.
Comments